<SEC-DOCUMENT>9999999995-20-002541-index.html : 20200924
<SEC-HEADER>9999999995-20-002541.hdr.sgml : 20200924
<ACCEPTANCE-DATETIME>20200924001511
ACCESSION NUMBER:		9999999995-20-002541
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200923
DATE AS OF CHANGE:		20200924
EFFECTIVENESS DATE:		20200923

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Taysha Gene Therapies, Inc.
		CENTRAL INDEX KEY:			0001806310
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				843199512
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-248559
		FILM NUMBER:		201193428

	BUSINESS ADDRESS:	
		STREET 1:		7318 MORTON STREET
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75209
		BUSINESS PHONE:		212.551.8702

	MAIL ADDRESS:	
		STREET 1:		7318 MORTON STREET
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75209
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>